2-methyl-N-propylpiperidine | 768-07-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2-methyl-N-propylpiperidine
• 英文别名: 2-methyl-1-propyl-piperidine；(+/-)-2-Methyl-1-propyl-piperidin；2-Methyl-1-propyl-piperidin；1-Propyl-2-methyl-piperidin；2-Methyl-1-propylpiperidin；2-Methyl-N-propylpiperidin；2-Methyl-1-propylpiperidine
• CAS: 768-07-0
• 化学式: C₉H₁₉N
• 分子量: 141.257
• InChiKey: MRVKZWJOSLLFML-UHFFFAOYSA-N

物化性质

• 沸点：
  156-166 °C
• 密度：
  0.823±0.06 g/cm3(Predicted)
• 保留指数：
  999

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-溴-2-己酮 在 盐酸 、 tin 、 水 作用下， 生成 2-methyl-N-propylpiperidine
  参考文献：
  名称：

  Ladenburg; Theodor, Justus Liebigs Annalen der Chemie, 1899, vol. 304, p. 76

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME<br/>[FR] COMPOSÉS 1,1'-BIPHÉNYLE SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ARBUTUS BIOPHARMA INC

  公开号：WO2021158481A1

  公开（公告）日：2021-08-12

  The present invention includes substituted 1,1'-biphenyl compounds, analogues thereof, and compositions comprising the same. In one aspect, the compounds contemplated in the invention can be used to treat, ameliorate, or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient. In another aspect, the compounds contemplated in the invention can be used to treat, ameliorate, and/or prevent cancer in a patient.

  本发明包括取代的1,1'-联苯化合物，其类似物，以及包含它们的组合物。在一个方面，本发明中考虑的化合物可用于治疗、改善或预防患者体内的乙型肝炎病毒（HBV）和/或丙型肝炎病毒（HDV）感染。在另一个方面，本发明中考虑的化合物可用于治疗、改善和/或预防患者体内的癌症。
• [EN] SMALL MOLECULE FATTY ACID SYNTHASE INHIBITORS<br/>[FR] INHIBITEURS DE SYNTHASE D'ACIDES GRAS À PETITES MOLÉCULES
  申请人：SANFORD BURNHAM MED RES INST

  公开号：WO2015134790A1

  公开（公告）日：2015-09-11

  Provided herein are small molecule Fatty Acid Synthase Inhibitors, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

  本文提供了小分子脂肪酸合成酶抑制剂，包括这些化合物的组合物，以及使用这些化合物和包括这些化合物的组合物的方法。
• [EN] IMPROVED, RED COLOUR FILTER COMPOSITION<br/>[FR] COMPOSITION DE FILTRE COLORÉ ROUGE AMÉLIORÉE
  申请人：BASF SE

  公开号：WO2009144115A1

  公开（公告）日：2009-12-03

  A composition, for producing dispersions, thermoplastic masses and/or colour filters, comprising (a) a colourant of formula (1) wherein 20-100 mol% R1 are Br and 80-100 mol% R3 are H, especially of formula (Ib) and /or (Ic); (b) from 0 to 150 % by weight, based on (a), of C. I. Pigment Red 144, 188, 190, 224, 242 or 2,4,6-trimethylphenylperylene diimide; (c) from 3 to 25 % by weight, based on (a), of a di- or tri-azacyclopentylmethyl-substituted colourant (formulae given); (d) from 0 to 10 % by weight, preferably from 0.01 to 8 % by weight, based on the sum of (a) and (b), of an additionally sulfonated colourant of the same kernels as in (c); and (e) from 0 to 30 % by weight, preferably from 3 to 25 % by weight, especially from 5 to 20 % by weight, based on (a), of a diketopyrrolopyrrole colourant substituted by at least one chain containing a plurality of nitrogen atoms (cf. formula (V)). The compound of formula (Ig), wherein R20 and R22 are, each independently of the other, H, Cl, Br, CN, CF3, R22, OR22, SR22, SOR22, SO2R22, NR23COR22, COOR23, CONR22R23, CONH2, CON(R22)2 or CON(R24), preferably Cl, Br, CN or R22, wherein R22, in each case independently of any other R22, is C1-C5alkyl, C2-C5alkylene, phenyl or 2-naphthyl, preferably methyl or phenyl, R23, in each case independently of any other R23, is H, d-C5alkyl or C2-C5alkylene, preferably H Or CH3, and R24, in each case independently of any other R24, is C4-C8alkylene which is uninterrupted or interrupted one or more times by NR23, NOR23, O, S, SO or by SO2, R24 in N(R24) forming with N a preferably 5- or 6-membered heterocyclic ring, with the proviso that R20 and R21 are not simultaneously Br and H, respectively, and also solid solutions thereof are likewise claimed. Also claimed is the compound of formula (Vb), wherein R27 is Br, Cl, F or methyl, R28 is H, C1-alkyl, or C6-C12alkyl wherein a carbon atom has been replaced by a nitrogen atom, and R29 is C6-C18alkyl wherein 1 or 2 carbon atoms has/have been replaced by nitrogen atom(s).

  一种用于生产分散体、热塑性质量和/或彩色滤光片的组合物，包括（a）式（1）的染料，其中20-100摩尔％的R1为Br，80-100摩尔％的R3为H，特别是式（Ib）和/或（Ic）;（b）相对于（a）的重量，从0到150％的C. I. Pigment Red 144、188、190、224、242或2,4,6-三甲基苯基苝二酰亚胺;（c）相对于（a）的重量，从3到25％的二或三-氮杂环戊基甲基取代的染料（给出式）;（d）相对于（a）和（b）的总和的重量，从0到10％的额外磺化的与（c）中相同核的染料，优选从0.01到8％的重量;（e）相对于（a）的重量，从0到30％的二酮吡咯吡咯染料，其取代至少含有一条含有多个氮原子的链（参见式（V））。式（Ig）的化合物，其中R20和R22分别独立于对方，为H、Cl、Br、CN、CF3、R22、OR22、SR22、SOR22、SO2R22、NR23COR22、COOR23、CONR22R23、CONH2、CON（R22）2或CON（R24），优选为Cl、Br、CN或R22，其中R22，每种情况独立于任何其他R22，为C1-C5烷基、C2-C5亚烷基、苯基或2-萘基，优选为甲基或苯基，R23，每种情况独立于任何其他R23，为H、d-C5烷基或C2-C5亚烷基，优选为H或CH3，和R24，每种情况独立于任何其他R24，为C4-C8亚烷基，其被NR23、NOR23、O、S、SO或SO2中断或中断一次或多次，R24在N（R24）中形成与N优选为5-或6-成员杂环环的环，但R20和R21不同时为Br和H，也同样要求其固体溶液。还要求的是式（Vb）的化合物，其中R27为Br、Cl、F或甲基，R28为H、C1-烷基或C6-C12烷基，其中一个碳原子被氮原子取代，R29为C6-C18烷基，其中1或2个碳原子被氮原子取代。
• SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS AND METHOD
  申请人：Cheng T. W. Peter

  公开号：US20070287713A1

  公开（公告）日：2007-12-13

  wherein Z 1 is (CH 2 ) q or C═O; Z 2 is (CH 2 ) p or C═O; D is —CH═ or C═O or (CH 2 ) m where m is 0, 1, 2 or 3; n=0, 1 or 2; p=1 or 2; q=0, 1 or 2; Q is C or N; A is (CH 2 ) x where x is 1 to 5, or A is (CH 2 ) x 1 , where x 1 is 1 to 5 with an alkenyl bond or an alkynyl bond embedded anywhere in the chain, or A is —(CH 2 ) x 2 —O—(CH 2 ) x 3 — where x 2 is 0 to 5 and x 3 is 0 to 5, provided that at least one of x 2 and x 3 is other than 0; B is a bond or is (CH 2 ) x 4 where x 4 is 1 to 5; X is CH or N; X 2 is C, N, O or S; X 3 is C, N, O or S; X 4 is C, N, O or S; X 5 is C, N, O or S; X 6 is C, N, O or S; provided that at least one of X 2 , X 3 , X 4 X 5 and X 6 is N; and at least one of X 2 , X 3 , X 4 X 5 and X 6 is C. R 1 is H or alkyl; R 2 is H, alkyl, alkoxy, halogen, amino, substituted amino or cyano; R 2a , R 2b and R 2c may be the same or different and are selected from H, alkyl, alkoxy, halogen, amino, substituted amino or cyano; and R 3 , E, Z and Y are as defined herein.

  其中Z1为(CH2)q或C═O；Z2为( )p或C═O；D为—CH═或C═O或( )m，其中m为0、1、2或3；n=0、1或2；p=1或2；q=0、1或2；Q为C或N；A为( )x，其中x为1到5，或A为( )x1，其中x1为1到5，具有烯丙基键或炔基键嵌入链中的任何位置，或A为—( )x2—O—( )x3—，其中x2为0到5，x3为0到5，前提是x2和x3中至少有一个不为0；B为键或( )x4，其中x4为1到5；X为CH或N；X2、X3、X4、X5和X6为C、N、O或S；前提是X2、X3、X4、X5和X6中至少有一个为N；并且X2、X3、X4、X5和X6中至少有一个为C。R1为H或烷基；R2为H、烷基、烷氧基、卤素、氨基、取代氨基或氰基；R2a、R2b和R2c可以相同也可以不同，选择自H、烷基、烷氧基、卤素、氨基、取代氨基或氰基；而R3、E、Z和Y的定义如前所述。
• Diaminopyrimidinecarboxamide Derivative
  申请人：Nagashima Shinya

  公开号：US20090281072A1

  公开（公告）日：2009-11-12

  A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.

  提供了一种可用于预防或治疗呼吸系统疾病，特别是哮喘、慢性阻塞性肺疾病等与STAT 6有关的化合物。该化合物为嘧啶衍生物或其盐，其在2位具有可被取代的芳基氨基或芳基乙基氨基基团，4位具有氨基取代的苯甲基基团或类似基团，5位具有可被取代的氨基甲酰基团。